Centessa Pharmaceuticals plc (CNTA) Earnings History
Net Loss6 years of earnings data (2020–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Centessa Pharmaceuticals plc (CNTA) Earnings Overview
As of June 12, 2026, Centessa Pharmaceuticals plc (CNTA) reported trailing twelve-month net income of -$251M, reflecting +29.1% year-over-year growth. The company earned $-1.63 per diluted share over the past four quarters, with a net profit margin of -1316.9%.
Looking at the long-term picture, CNTA's historical earnings data spans multiple years. The company achieved its highest annual net income of -$11M in fiscal 2020.
Centessa Pharmaceuticals plc is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including KYMR (-$315M net income, -794.4% margin), IMVT (-$506M net income), ARQT (-$2M net income, -4.3% margin), CNTA has room to improve margins relative to the peer group. Compare CNTA vs KYMR →
CNTA Earnings vs Peers
Earnings metrics vs comparable public companies
CNTA Historical Earnings Data (2020–2025)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$198M | +16.2% | -$208M | $-1.46 | -1316.9% | -1384.6% |
| 2024 | -$236M | -56.0% | -$201M | $-2.06 | - | - |
| 2023 | -$151M | +30.1% | -$171M | $-1.57 | -2204.7% | -2499.4% |
| 2022 | -$216M | +43.4% | -$212M | $-2.31 | - | - |
| 2021 | -$382M | -3481.5% | -$375M | $-4.24 | - | - |
| 2020 | -$11M | - | -$10M | $-0.08 | - | - |
Download Data
Export CNTA earnings history in CSV or JSON format
Free sign-in required to download data
What if you invested $1,000 in CNTA back in 2020?
Total return with dividends reinvested · 6+ years of data
Calculate ReturnsHow much would $100/month in CNTA be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs CNTA Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCNTA vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowCNTA — Frequently Asked Questions
Quick answers to the most common questions about buying CNTA stock.
What is CNTA earnings per share (EPS)?
CNTA trailing twelve-month (TTM) diluted EPS is $-1.63, reflecting +29.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2020 to 2025 is available in the table on this page.
What is Centessa Pharmaceuticals plc's net income?
Centessa Pharmaceuticals plc (CNTA) trailing twelve-month net income is $-251M as of 2025. Earnings grew +29.1% year-over-year.
Is CNTA profitable?
CNTA is not currently profitable on a TTM basis, reporting a net loss of $-251M. Net margin is -1316.9%. Investors should monitor for a return to profitability.
What is CNTA's earnings growth rate?
CNTA compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2020 to 2025.
What are CNTA's profit margins?
Centessa Pharmaceuticals plc net profit margin is -1316.9%, operating margin is -1384.6%, and gross margin is +100.0%. Below-average margins reflect competitive or cost pressures. Return on Equity is -42.6%.
Is CNTA growing earnings?
Yes, CNTA earnings are accelerating — EPS growth of +29.1% exceeds the 5-year CAGR of N/A. TTM net income reached $-251M. Earnings momentum is strengthening.
What was CNTA's best earnings year?
Centessa Pharmaceuticals plc's highest annual net income on record is $-11M, achieved in fiscal year 2020. Earnings history on this page spans 2020 to 2025 and includes all annual and quarterly figures.
What were CNTA's earnings last quarter?
CNTA's most recent reported quarter was Q1 2026. Net income was $-79M with diluted EPS of $-0.52. For a full breakdown of all quarters, see the quarterly earnings table on this page.